reference/36407761

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36407761

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	743.e10
issn	2213-2198
issueIdentifier	3
pageRange	733-743.e10
publicationName	The Journal of Allergy and Clinical Immunology: In Practice
startingPage	733
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_847bbdff7a7ab73d9cf2ca37443a2b1b
bibliographicCitation	Kiani-Alikhan S, Gower R, Craig T, Wedner HJ, Kinaciyan T, Aygören-Pürsün E, Banerji A, Bernstein JA, Anderson J, Collis P, Johnston DT, Desai B, Tomita D, Gagnon R, Tachdjian R, Soteres DF, Farkas H, Caballero T, McNeil D, Jacobs J, Lumry WR; APeX-2 investigators. Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial. J Allergy Clin Immunol Pract. 2024 Mar;12(3):733–743.e10. doi: 10.1016/j.jaip.2023.12.019. PMID: 38122865.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45875393bbabfd24d0e45fd33043644b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5834ecdde9a06f5dd12ded46c910fe70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b340bb2014e84a81cbba4ff214145b64 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9719f8b073d5c955c729e7e4138fbb69 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d594c03ae2dbdba15ce1047c478ab1ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_474cfecae7f151250dcf1468229708ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5091ca9e888a143a084e112afb3d173 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_165262fa927926c5c8007a9e1129ad7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab02b1e5ae75311c8f30660beb04ecdf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_296157bba8fcce1b4ecdf1abc644360f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_501f7642d3f46bb31b313abac8a54313 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7bc0486b1ce4610ebc04e603a8bc7dd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e08112a1dd6c6d1b5d689738246b6dc4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb5ec90fcbe62a1215b10b5efe81c568 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d12ab086542194d03fa4f73547677044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3aed5784fb4f74be7f4ec2e739ba4044 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_babbf4b160d973cb1c0f14ddabc86838 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_94f4f145c826de6c290c7688d31c472b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa444138a17d4f3694af148da1fde770 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16c6f9d8ca229c4e0d55c46b891a4587 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bcc89da01b6fc0f7bde988c363a35520
date	202403
identifier	https://pubmed.ncbi.nlm.nih.gov/38122865 https://doi.org/10.1016/j.jaip.2023.12.019
isPartOf	https://portal.issn.org/resource/ISSN/2213-2198 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40850
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Once-Daily Oral Berotralstat for Long-Term Prophylaxis of Hereditary Angioedema: The Open-Label Extension of the APeX-2 Randomized Trial
discusses	http://id.nlm.nih.gov/mesh/M000733815 http://id.nlm.nih.gov/mesh/M0018226 http://id.nlm.nih.gov/mesh/M0476632
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D054179Q000517 http://id.nlm.nih.gov/mesh/D011720 http://id.nlm.nih.gov/mesh/D054179Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D050718Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016896

Showing number of triples: 1 to 50 of 50.